Treatment of severe perinuclear antineutrophil cytoplasmic antibody–associated vasculitis with efgartigimod

• DOI: 10.1016/j.jdcr.2024.03.005
• Publication Date: 2024-03-15T08:52:00Z
• Authors: Afsoon Ghafari-Sa...; Alana Haussmann; Jessica Wu; Kyle Cheng
• Keywords: perinuclear anti-neutrophil cytoplasmic antibodies; Biomedical and Clinical Sciences; RL1-803; Clinical Sciences; P-ANCA vasculitis; efgartigimod; Clinical sciences; autoimmune disease; immunomodulatory therapy; Case Report; Dermatology; vasculitis